Generation of T cells with reduced off-target cross-reactivities by engineering co-signalling receptors
{{output}}
Adoptive T cell therapy using T cells engineered with novel T cell receptors (TCRs) targeting tumour-specific peptides is a promising immunotherapy. However, these TCR-T cells can cross-react with off-target peptides, leading to severe autoimmune toxicities. C... ...
